# The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma

> **NCT03255330** · PHASE3 · WITHDRAWN · sponsor: **Masaryk University**

## Conditions studied

- Chronic Pain Due to Trauma
- Spinal Cord Injuries

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Metamizol
- **DRUG:** Tramadol

## Key facts

- **NCT ID:** NCT03255330
- **Lead sponsor:** Masaryk University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10
- **Primary completion:** 2020-02
- **Final completion:** 2020-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participant enrolled
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255330, "The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03255330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*